Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,171
Closed -$676K 821
2025
Q1
$676K Buy
+2,171
New +$641K 0.04% 476
2024
Q2
Sell
-16,276
Closed -$4.63M 573
2024
Q1
$4.63M Buy
+16,276
New +$4.76M 0.33% 53
2023
Q1
Sell
-1,363
Closed -$358K 952
2022
Q4
$358K Sell
1,363
-20,561
-94% -$5.51M 0.02% 739
2022
Q3
$4.94M Sell
21,924
-7,193
-25% -$1.74M 0.32% 45
2022
Q2
$7.08M Buy
29,117
+25,068
+619% +$6.14M 0.38% 38
2022
Q1
$979K Buy
+4,049
New +$930K 0.05% 468
2020
Q3
Sell
-7,962
Closed -$1.88M 1461
2020
Q2
$1.88M Buy
+7,962
New +$1.82M 0.05% 683
2019
Q4
Sell
-109,175
Closed -$21.1M 1530
2019
Q3
$21.1M Buy
109,175
+54,450
+99% +$10.5M 0.25% 132
2019
Q2
$10.1M Buy
54,725
+53,033
+3,134% +$9.5M 0.2% 171
2019
Q1
$321K Buy
1,692
+174
+11% +$33.2K 0.01% 775
2018
Q4
$296K Sell
1,518
-311
-17% -$60.7K 0.01% 667
2018
Q3
$379K Sell
1,829
-682
-27% -$134K 0.01% 728
2018
Q2
$464K Sell
2,511
-2,664
-51% -$471K 0.01% 657
2018
Q1
$882K Buy
5,175
+716
+16% +$131K 0.02% 550
2017
Q4
$775K Sell
4,459
-45,946
-91% -$8.13M 0.02% 427
2017
Q3
$9.4M Buy
50,405
+29,264
+138% +$5.19M 0.3% 89
2017
Q2
$3.64M Sell
21,141
-119,663
-85% -$19.5M 0.11% 210
2017
Q1
$23.1M Buy
140,804
+33,616
+31% +$5.59M 0.63% 43
2016
Q4
$15.7M Sell
107,188
-134,430
-56% -$20.2M 0.52% 60
2016
Q3
$40.3M Sell
241,618
-73,551
-23% -$12.4M 0.69% 35
2016
Q2
$48M Sell
315,169
-16,912
-5% -$2.63M 0.79% 28
2016
Q1
$49.8M Sell
332,081
-11,305
-3% -$1.68M 0.54% 60
2015
Q4
$55.7M Sell
343,386
-52,860
-13% -$8.31M 0.5% 66
2015
Q3
$54.8M Buy
396,246
+22,868
+6% +$3.6M 0.43% 71
2015
Q2
$57.3M Buy
373,378
+138,022
+59% +$22.1M 0.53% 54
2015
Q1
$37.6M Buy
235,356
+150,178
+176% +$23.7M 0.3% 128
2014
Q4
$13.6M Sell
85,178
-46,161
-35% -$7.19M 0.17% 215
2014
Q3
$18.4M Sell
131,339
-192,143
-59% -$25.1M 0.13% 266
2014
Q2
$38.3M Buy
+323,482
New +$37.4M 0.26% 160

Other funds holding AMGN

Winton Group's AMGN Position: Q2 2025 in Review

Winton Group sold out of Amgen (AMGN) in Q2 2025, closing a stake of 2,171 shares — an estimated $676K sold.

Winton Group first reported a position in AMGN in Q2 2014 and held it in 29 quarters. The position peaked at $57.3M in Q2 2015. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Winton Group reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
  • Winton Group sold 2,171 Amgen shares in Q2 2025, an estimated $676K.
  • Winton Group first reported a position in Amgen in Q2 2014 and held it in 29 quarters.
  • Winton Group's Amgen position peaked at $57.3M in Q2 2015.
  • 2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Winton Group's 13F filing for Q2 2025, filed 14 Aug 2025.